(6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide

C17H22FN5O2 — CID 136727612

IUPAC(6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCOc1ccc(F)cc1[C@H](C)NC[C@H]1CNc2c(C(N)=O)cnn2C1
InChIInChI=1S/C17H22FN5O2/c1-10(13-5-12(18)3-4-15(13)25-2)20-6-11-7-21-17-14(16(19)24)8-22-23(17)9-11/h3-5,8,10-11,20-21H,6-7,9H2,1-2H3,(H2,19,24)/t10-,11-/m0/s1
InChIKeyYZPQMZNAZYWVJW-QWRGUYRKSA-N
MW347.39 g/mol
LogP1.52
Rot. Bonds6

About (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide

(6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 136727612) has the molecular formula C17H22FN5O2 and a molecular weight of 347.39 g/mol. Its IUPAC name is (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound Name(6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID136727612
Molecular FormulaC17H22FN5O2
Molecular Weight347.39 g/mol
Exact Mass347.18
IUPAC Name(6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCOc1ccc(F)cc1[C@H](C)NC[C@H]1CNc2c(C(N)=O)cnn2C1
InChIInChI=1S/C17H22FN5O2/c1-10(13-5-12(18)3-4-15(13)25-2)20-6-11-7-21-17-14(16(19)24)8-22-23(17)9-11/h3-5,8,10-11,20-21H,6-7,9H2,1-2H3,(H2,19,24)/t10-,11-/m0/s1
InChIKeyYZPQMZNAZYWVJW-QWRGUYRKSA-N
XLogP1.52
TPSA94.20 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500347.39
LogP ≤ 51.52
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 136727612) is (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide is COc1ccc(F)cc1[C@H](C)NC[C@H]1CNc2c(C(N)=O)cnn2C1.
What is the InChIKey of (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is YZPQMZNAZYWVJW-QWRGUYRKSA-N. The full InChI is InChI=1S/C17H22FN5O2/c1-10(13-5-12(18)3-4-15(13)25-2)20-6-11-7-21-17-14(16(19)24)8-22-23(17)9-11/h3-5,8,10-11,20-21H,6-7,9H2,1-2H3,(H2,19,24)/t10-,11-/m0/s1.
What are the key properties of (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide?
(6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 347.39 g/mol, XLogP of 1.52, 6 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (6S)-6-[[[(1S)-1-(5-fluoro-2-methoxyphenyl)ethyl]amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 136727612), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).